M/CLEAR
Moderna and Pfizer’s bivalent booster vaccines failed to develop levels of protective proteins called neutralizing antibodies against dominant strains of omicron in more than four doses of the original COVID-19 vaccines, according to an initial independent study by a small organization of people.
Researchers at Columbia University and levels of protective proteins from the University of Michigan, called neutralizing antibodies, in blood samples from 21 other people who received a fourth injection of the bivalent boosters Moderna or Pfizer-BioNTech SE compared to antibody levels in 19 other people who gained 4 of the original vaccine shots.
This is possibly due to a conflict with your security or ad-blocking software.
Upload japantimes. co. jp and piano. io to your list of sites.
If this doesn’t work or if you can’t load the domain names on your whitelist, stop by this help page.
We humbly for the inconvenience.
In an age of misinformation and too much information, quality journalism is more important than ever. By subscribing, you can help us tell the story well.
Your subscription plan allows you to comment. To be more informed, see our frequently asked questions
Japan Times Ltd. All rights reserved.